Living Kidney Donors at Increased Risk for Hypertension
In a study, kidney donation was associated with higher risk for hypertension, regardless of race.
All articles by Natasha Persaud
Metformin Superior for Lowering CV Risk in Diabetics Who Progress to CKD
Continued monotherapy with metformin, compared with a sulfonylurea, is associated with a lower risk for major adverse cardiovascular events (MACE) among patients with type 2 diabetes who experienced reduced kidney function.
Both Genes, Environment Contribute to Metabolic Syndrome-CKD Link
In a study of Swedish twins, investigators worked out the relative effects of genes and the environment on the correlation between metabolic syndrome and chronic kidney disease.
Women Have Lower Relative Survival After Bladder Cancer Diagnosis
In a study, women with bladder cancer had approximately 1.5-fold higher mortality than men — but only in the short term.
Surgery Alone Can Improve Mixed Urinary Incontinence Symptoms
In a study, investigators did not observe a clinically important difference between midurethral sling surgery patients who did and did not receive perioperative behavioral therapies.
Creatinine Rises After RAS Inhibitor Initiation Tied to Worse Outcomes
Creatinine increases exceeding 10% within 2 months of initiating renin angiotensin system inhibitors were consistently associated with greater risks.
HCV-Infected Donor Kidneys Offer Good Short-Term Graft Function
Kidney transplant recipients who received an HCV-infected kidney had similar allograft function at 1 year to those receiving an uninfected kidney: 66.3 vs 67.1 mL/min/1.73m2, respectively.
Data Support Confirmatory MRI-Guided Prostate Biopsy Before AS
Confirmatory biopsy with MRI guidance provides a more accurate risk assessment than a conventional transrectal ultrasound confirmatory biopsy, according to researchers.
Can Testosterone Therapy Lower Prostate Cancer Risk?
In a study, investigators observed a reduced probability of prostate cancer in nondiabetic men with greater use of testosterone therapy.
Review: SGLT2 Inhibitors Provide Clear Renal Benefits in Type 2 Diabetes
New review identifies benefits of sodium-glucose co-transporter-2 (SGLT2) inhibitors at almost all levels of kidney function.
Next post in Diabetic Nephropathy
